# Safety and Efficacy Study of Lotus Valve for Transcatheter Aortic Valve Replacement

Study · id `cardio:ct-nct02202434` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02202434](<https://clinicaltrials.gov/study/NCT02202434>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02202434

Browse, organ or system: Heart  
Browse, condition area: Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 1425 participants.

## Technical summary

Registry record NCT02202434. Randomized; no masking; primary purpose treatment. Start 2014-09-22 (actual); primary completion 2017-03-08 (actual). Results posted on 2019-07-30.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 1425 participants (enrolled count; ClinicalTrials.gov record NCT02202434, source copy `cardio:ctgov-nct02202434-2021-12-17`, retrieved 2026-10-26)
- Started: 2014-09-22 (actual) (ClinicalTrials.gov record NCT02202434, source copy `cardio:ctgov-nct02202434-2021-12-17`, retrieved 2026-10-26)
- Primary completion: 2017-03-08 (actual) (ClinicalTrials.gov record NCT02202434, source copy `cardio:ctgov-nct02202434-2021-12-17`, retrieved 2026-10-26)
- Completion: 2021-05-21 (actual) (ClinicalTrials.gov record NCT02202434, source copy `cardio:ctgov-nct02202434-2021-12-17`, retrieved 2026-10-26)
- Results first posted: 2019-07-30 (ClinicalTrials.gov record NCT02202434, source copy `cardio:ctgov-nct02202434-2021-12-17`, retrieved 2026-10-26)
- Countries: United States; Australia; Canada; France; Germany; Netherlands (ClinicalTrials.gov record NCT02202434, source copy `cardio:ctgov-nct02202434-2021-12-17`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "TERMINATED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02202434-2021-12-17`, retrieved 2026-10-26)

## The registry's words

- Brief title: Safety and Efficacy Study of Lotus Valve for Transcatheter Aortic Valve Replacement
- Acronym: REPRISE III
- Condition: Aortic Stenosis
- Intervention (Device): Lotus Valve System
- Intervention (Device): CoreValve/Evolut R Transcatheter Aortic Valve Replacement System
- Intervention (Device): LOTUS Edge Valve System
- Lead sponsor: Boston Scientific Corporation
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Aortic stenosis (`cardio:aortic-stenosis`)
- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry lists this organization as the lead sponsor: Boston Scientific (`cardio:boston-scientific`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Effect of Mechanically Expanded vs Self-Expanding Transcatheter Aortic Valve Replacement on Mortality and Major Adverse Clinical Events in High-Risk Patients With Aortic Stenosis: The REPRISE III Randomized Clinical Trial (`cardio:pubmed-29297076`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Hemodynamic and Echocardiographic Comparison of the Lotus and CoreValve Transcatheter Aortic Valves in Patients With High and Extreme Surgical Risk: An Analysis From the REPRISE III Randomized Controlled Trial (`cardio:pubmed-29530883`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Two-Year Outcomes After Transcatheter Aortic Valve Replacement With Mechanical vs Self-expanding Valves: The REPRISE III Randomized Clinical Trial (`cardio:pubmed-30810703`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Pacemaker Implantation and Dependency After Transcatheter Aortic Valve Replacement in the REPRISE III Trial (`cardio:pubmed-31640455`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Clinical Implications of Physical Function and Resilience in Patients Undergoing Transcatheter Aortic Valve Replacement (`cardio:pubmed-32856530`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Long-term Outcomes of Transcatheter Aortic Valve Replacement With the Lotus Valve vs CoreValve/EvolutR: A Secondary Analysis of the REPRISE III Randomized Clinical Trial (`cardio:pubmed-36301543`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 490908958bce11f3de022b69ae591c70e1443f6455d9eaa378601a37e87b750d
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
